GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.

Myśliwczyk D, Myśliwiec M, Minarowska A, Wasilewska E

Open source

DOI
10.3390/ijms27188191
Published
2026 Sep 15
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27188191,
  title = {GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.},
  author = {Myśliwczyk D and Myśliwiec M and Minarowska A and Wasilewska E},
  year = {2026},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms27188191},
  url = {https://doi.org/10.3390/ijms27188191}
}

RIS

TY  - JOUR
TI  - GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.
AU  - Myśliwczyk D
AU  - Myśliwiec M
AU  - Minarowska A
AU  - Wasilewska E
PY  - 2026
JO  - International journal of molecular sciences
DO  - 10.3390/ijms27188191
UR  - https://doi.org/10.3390/ijms27188191
ER  - 

APA

D, M., M, M., A, M., & E, W. (2026). GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Pediatric Obesity: From Neuroendocrine Mechanisms to Clinical Application.. International journal of molecular sciences. https://doi.org/10.3390/ijms27188191

Source records